Current Management and Future Perspectives of Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer

被引：0

作者：

Gilchrist, Jenny ^{[1
,2
]}

机构：

[1] Macquarie Univ Hosp, Sydney, NSW, Australia

[2] Macquarie Univ, Macquarie Univ Hosp, 3 Technol Pl, Sydney, NSW 2109, Australia

来源：

SEMINARS IN ONCOLOGY NURSING | 2024年 / 40卷 / 01期

关键词：

Advanced breast cancer; Endocrine therapy; Hormone receptor-positive; Nursing; HER2-negative; FIRST-LINE THERAPY; POSTMENOPAUSAL WOMEN; ENDOCRINE THERAPY; AROMATASE INHIBITORS; 1ST-LINE THERAPY; DOUBLE-BLIND; PHASE-III; TAMOXIFEN; MULTICENTER; LETROZOLE;

D O I：

10.1016/j.soncn.2023.151547

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Objectives: An overview of the best therapeutic approaches for the management of hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer is provided, and emerging treatment advances are discussed. Key nursing considerations and the role of the nurse in the provision of optimal care are explored. Data Sources: Data sources include peer-reviewed articles sourced in electronic databases. Conclusion: With a multitude of current and emerging treatments for the management of hormone receptor-positive, HER2-negative advanced breast cancer, patients with this subtype have improved overall survival. It is essential that specialist nurses holistically support patients; this will ensure treatment adherence, leading to enhanced longevity and quality of life. Implications for Nursing Practice: Nurses play an important role in patient education and the early identification and management of treatment toxicities. Nurses also need to monitor and facilitate adherence by identifying barriers and implementing strategies to overcome them, ultimately improving patient outcomes. (c) 2023 The Author. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)

引用

页数：5

共 49 条

[1] Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR) [J].

Alomran, Reem ;

White, Michelle ;

Bruce, Melissa ;

Bressel, Mathias ;

Roache, Susan ;

Karroum, Lama ;

Hanna, Gerard G. ;

Siva, Shankar ;

Goel, Shom ;

David, Steven .

BMC CANCER, 2021, 21 (01)

[2] Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer [J].

Andre, Fabrice ;

Ciruelos, Eva ;

Rubovszky, Gabor ;

Campone, Mario ;

Loibl, Sibylle ;

Rugo, Hope S. ;

Iwata, Hiroji ;

Conte, Pierfranco ;

Mayer, Ingrid A. ;

Kaufman, Bella ;

Yamashita, Toshinari ;

Lu, Yen-Shen ;

Inoue, Kenichi ;

Takahashi, Masato ;

Papai, Zsuzsanna ;

Longin, Anne-Sophie ;

Mills, David ;

Wilke, Celine ;

Hirawat, Samit ;

Juric, Dejan .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (20) :1929-1940

[3] Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial [J].

Antonuzzo, Andrea ;

Ripamonti, Carla Ida ;

Roila, Fausto ;

Sbrana, Andrea ;

Galli, Luca ;

Miccinesi, Guido ;

Sammarco, Enrico ;

Berruti, Alfredo ;

Coletta, Deborah ;

Velutti, Laura ;

Fabi, Alessandra ;

Corsi, Domenico Cristiano ;

Mariani, Gabriella ;

Di Pede, Patricia ;

Spinelli, Gian Paolo ;

Santini, Daniele ;

Zustovich, Fable ;

Gunnellini, Marco ;

Rossi, Maura ;

Giordano, Monica ;

Di Maio, Massimo ;

Numico, Gianmauro ;

Bossi, Paolo .

FRONTIERS IN ONCOLOGY, 2022, 12

[4] Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial [J].

Bidard, Francois-Clement ;

Kaklamani, Virginia G. ;

Neven, Patrick ;

Streich, Guillermo ;

Montero, Alberto J. ;

Forget, Frederic ;

Mouret-Reynier, Marie-Ange ;

Sohn, Joo Hyuk ;

Taylor, Donatienne ;

Harnden, Kathleen K. ;

Khong, Hung ;

Kocsis, Judit ;

Dalenc, Florence ;

Dillon, Patrick M. ;

Babu, Sunil ;

Waters, Simon ;

Deleu, Ines ;

Saenz, Jose A. Garcia ;

Bria, Emilio ;

Cazzaniga, Marina ;

Lu, Janice ;

Aftimos, Philippe ;

Cortes, Javier ;

Liu, Shubin ;

Tonini, Giulia ;

Laurent, Dirk ;

Habboubi, Nassir ;

Conlan, Maureen G. ;

Bardia, Aditya .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) :3246-+

[5] 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) [J].

Cardoso, F. ;

Paluch-Shimon, S. ;

Senkus, E. ;

Curigliano, G. ;

Aapro, M. S. ;

Andre, F. ;

Barrios, C. H. ;

Bergh, J. ;

Bhattacharyya, G. S. ;

Biganzoli, L. ;

Boyle, F. ;

Cardoso, M-J ;

Carey, L. A. ;

Cortes, J. ;

El Saghir, N. S. ;

Elzayat, M. ;

Eniu, A. ;

Fallowfield, L. ;

Francis, P. A. ;

Gelmon, K. ;

Gligorov, J. ;

Haidinger, R. ;

Harbeck, N. ;

Hu, X. ;

Kaufman, B. ;

Kaur, R. ;

Kiely, B. E. ;

Kim, S-B ;

Lin, N. U. ;

Mertz, S. A. ;

Neciosup, S. ;

Offersen, B., V ;

Ohno, S. ;

Pagani, O. ;

Prat, A. ;

Penault-Llorca, F. ;

Rugo, H. S. ;

Sledge, G. W. ;

Thomssen, C. ;

Vorobiof, D. A. ;

Wiseman, T. ;

Xu, B. ;

Norton, L. ;

Costa, A. ;

Winer, E. P. .

ANNALS OF ONCOLOGY, 2020, 31 (12) :1623-1649

[6] Barriers and facilitators to taking CDK4/6 inhibitors among patients with metastatic breast cancer: a qualitative study [J].

Conley, Claire C. ;

McIntyre, McKenzie ;

Pensak, Nicole A. ;

Lynce, Filipa ;

Graham, Deena ;

Ismail-Khan, Roohi ;

Lopez, Katherine ;

Vadaparampil, Susan T. ;

O'Neill, Suzanne C. .

BREAST CANCER RESEARCH AND TREATMENT, 2022, 192 (02) :385-399

[7] Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial [J].

Cristofanilli, Massimo ;

Turner, Nicholas C. ;

Bondarenko, Igor ;

Ro, Jungsil ;

Im, Seock-Ah ;

Masuda, Norikazu ;

Colleoni, Marco ;

DeMichele, Angela ;

Loi, Sherene ;

Verma, Sunil ;

Iwata, Hiroji ;

Harbeck, Nadia ;

Zhang, Ke ;

Theall, Kathy Puyana ;

Jiang, Yuqiu ;

Bartlett, Cynthia Huang ;

Koehler, Maria ;

Slamon, Dennis .

LANCET ONCOLOGY, 2016, 17 (04) :425-439

[8] Combination versus sequential single agent chemotherapy for metastatic breast cancer [J].

Dear, Rachel F. ;

McGeechan, Kevin ;

Jenkins, Marisa C. ;

Barratt, Alexandra ;

Tattersall, Martin H. N. ;

Wilcken, Nicholas .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12)

[9] Cancer statistics for African Americans, 2019 [J].

DeSantis, Carol E. ;

Miller, Kimberly D. ;

Sauer, Ann Goding ;

Jemal, Ahmedin ;

Siegel, Rebecca L. .

CA-A CANCER JOURNAL FOR CLINICIANS, 2019, 69 (03) :211-233

[10]

Finn RS, 2022, J CLIN ONCOL, V40

← 1 2 3 4 5 →